Measuring molecular responses to tyrosine kinase inhibitors in chronic myeloid leukaemia ecancer

Prof Branford (Adelaide University Adelaide, Australia) talks to ecancertv at EHA 2015 about differences in molecular responses to tyrosine kinase inhibitors in chronic myeloid leukaemia and how decisions can be made about stopping the treatment.